ORGO
Organogenesis Holdings Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.42
+4.41%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.18
- Revenue estimate
- $52.1M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.71
- EPS estimate
- -$0.35
- Revenue actual
- $43.8M
- Revenue estimate
- $54.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -93.3%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.35 | -$0.71 | Miss -102.86% | $43.8M |
| May 7, 2026 | -$0.29 | -$0.37 | Miss -27.59% | $36.3M |
| Nov 6, 2025 | $0.21 | $0.18 | Miss -14.29% | $150.9M |
| Aug 7, 2025 | $0.07 | -$0.09 | Miss -228.57% | $101.0M |
| May 8, 2025 | $0.04 | -$0.13 | Miss -425.00% | $86.7M |
| Feb 27, 2025 | -$0.03 | $0.04 | Beat 233.33% | $126.7M |
| Aug 8, 2024 | -$0.02 | -$0.13 | Miss -550.00% | $130.2M |
| May 9, 2024 | -$0.02 | -$0.02 | Miss -25.00% | $110.0M |
| Feb 29, 2024 | -$0.00 | -$0.00 | Miss -100.47% | $99.7M |
| Nov 9, 2023 | $0.01 | $0.02 | Beat 300.00% | $108.5M |
| May 10, 2023 | -$0.02 | -$0.02 | In line | $107.6M |
| Mar 1, 2023 | $0.05 | $0.06 | Beat 20.00% | $115.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026